Belrose Pharma Inc (Belrose)

Oncology Corporate Profile

HQ Location

3000 Eastpark Blvd.
Cranbury, NJ 8512

Company Description

Belrose Pharma Inc. is a privately-held clinical-stage biopharmaceutical company focused on the development of new treatments for orphan diseases and other conditions with high unmet medical needs. Belrose Pharma currently has two Phase 2/3 clinical programs and two additional earlier stage candidates with the potential for accelerated approval based on an abbreviated approval pathway.


This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
BEL-0222angiogenesis inhibitorBreast cancerII
PEG-SN38angiogenesis inhibitorBreast cancerII
PEG-SN38angiogenesis inhibitorPediatric NeuroblastomaI

View additional information on product candidates here »


Recent News Headlines

There are no news items to display